Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Norman Biological is a China-based in vitro diagnostics and medical technology company focused on immunodiagnostic instruments, reagents, and upstream IVD raw materials. Founded in 2008 in Nanjing, the company develops and manufactures chemiluminescence immunoassay systems, POCT immunofluorescence platforms, diagnostic kits, and core inputs such as antigens, antibodies, and magnetic beads. Its products are used across hospital laboratories, particularly in emergency and outpatient testing, with menu coverage spanning infectious disease, cardiovascular, tumor, autoimmune, endocrine, coagulation, and metabolic testing. The company reports broad domestic hospital penetration in China and exports CE-marked products internationally. Norman Biological appears to be a commercial-stage private diagnostics manufacturer rather than a therapeutics developer, so it does not present a conventional drug pipeline.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Norman Biological.